While many 21-year-olds celebrate their coming of age in bars and nightclubs, Andrew Solis is celebrating freedom by finally going home—equipped with a new heart and liver—after nearly eight months at Cedars-Sinai.
David M. Wrigley has been promoted to executive vice president and chief financial officer of Cedars-Sinai Health System, effective July 1.
Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator.
Investigators from Cedars-Sinai will present the latest novel stem cell and regenerative medicine research at the International Society for Stem Cell Research (ISSCR) Annual Meeting, which is being held in person and virtually June 15-19 in San Francisco.
Investigators from the Women’s Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).
Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.
Experts from Cedars-Sinai Cancer are available to comment on the American Association for Cancer Research (AACR) Cancer Disparities Progress Report 2022, which will be released Wednesday, June 8, in a virtual congressional briefing. The report highlights the need to increase diversity in clinical trials and the cancer workforce, and it provides policy recommendations for addressing cancer disparities—all areas Cedars-Sinai Cancer is working to address.
Recently, Michael Wulfe, who is 61 and lives in West Hollywood, was on the phone with his sister, Stephanie Wulfe, in Dallas. They talk at least once a day, but that day, something wasn’t right. “I was talking, and then I didn’t have the words,” Wulfe said. “My sister immediately said, ‘Call Cedars-Sinai!’”
Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons continuously funded by the National Institutes of Health for a decade, has been appointed vice chair of the Department of Cardiac Surgery in the Smidt Heart Institute.
Cedars-Sinai clinicians and scientists, including anti-rejection therapy pioneer Stanley Jordan, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 4-8, 2022, in Boston. The ATC is the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.
Results of a Phase II clinical trial led by Cedars-Sinai Cancer investigators indicate that an immunotherapy drug combination could extend the lives of those diagnosed with advanced non-small cell lung cancer, one of the most common forms of lung cancer. The research was presented today during the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, with simultaneous publication in the peer-reviewed Journal of Clinical Oncology.
Physicians and scientists from Cedars-Sinai will discuss the latest advances in treatment, care and research at the Endocrine Society’s annual meeting (ENDO 2022) in Atlanta, June 11-14.
Patients newly diagnosed with cancer typically focus on one question, eclipsing all others: “What is my prognosis?”
Investigators at Cedars-Sinai have comprehensively mapped molecular activity in the brain and spinal cord that is responsible for regulating the body's response to central nervous system (CNS) disorders such as Alzheimer’s, Huntington's disease and spinal cord injuries.
Cedars-Sinai and Space Tango are launching pilot-scale systems for the in-space production of stem cells to see if they can elevate the next generation of stem cell and gene therapies by harnessing the near-zero gravity conditions of spaceflight.
Like a lot of young children, from the time she was a year old, Cassidy Clapp was plagued by one ear infection after another.
Graciela Gonzalez-Hernandez, PhD, has been named vice chair of Cedars-Sinai’s Department of Computational Biomedicine. In this position, Gonzalez-Hernandez will focus on collaborating with investigators across the Cedars-Sinai Health System and expanding Cedars-Sinai’s artificial intelligence and machine-learning capabilities.
Cedars-Sinai investigators have identified a gene that plays an essential role in the innate human immune system. The gene, NLRP11, helps activate the inflammatory response that tells the body’s white blood cells to go on the attack against a foreign presence.
Experts from Cedars-Sinai Cancer, ranked among the top 10 in the nation for cancer care, will present novel research and clinical advances throughout the 2022 annual meeting of the American Society of Clinical Oncology (ASCO), taking place in person and virtually June 3-7 in Chicago.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Multiple cases of monkeypox have surfaced in Europe and the U.S. that do not appear to be linked to travel, causing concern among the medical community that this infectious disease is spreading through sexual contact or other close interactions.
Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.
Roma Gianchandani, MD, has joined Cedars-Sinai as the new medical director of Diabetes Quality and vice-chair of Quality and Innovation.
The 2022 Annual Report from Cedars-Sinai Cancer, which is available now, shines a spotlight on ways this expert team, ranked among the top 10 in the nation for cancer care by U.S. News & World Report, has treated more than 60 types of cancer while honoring and expanding a long-standing commitment to health equity.
Cedars-Sinai is joining the cities of Los Angeles and West Hollywood in celebrating June as Pride Month, which honors the LGBTQ+ community.
A new study co-led by a Cedars-Sinai investigator identified a gene that plays an important role in a biological pathway involved in embryo development. The gene's impact at the cellular level could explain why some babies are born with physical abnormalities and why some adults develop diseases such as cancer. The findings are published in Nature Communications.
Behind orthopaedic nurse Paulina Andujo' s contagious smile lies not only a compassionate caregiver but also a unique talent.
Getting the COVID-19 vaccination strengthened one type of immune response to the SARS-CoV-2 virus in inflammatory bowel disease (IBD) patients even though they were taking immunosuppressant medication, according to investigators at Cedars-Sinai.
Following a nationwide search, Christina Harris, MD, has been named vice president and chief health equity officer for Cedars-Sinai. In this strategic leadership position, Harris will guide Cedars-Sinai's ongoing efforts to promote health equity, address health disparities and foster wellness across the organization and the communities we serve.
Shlomo Melmed, MB, ChB, a world-renowned leader in pituitary medicine, was named the inaugural recipient of the Transatlantic Alliance Award by the European Society of Endocrinology (ESE) and the Endocrine Society for his pioneering research in pituitary medicine and endocrine tumors.
Two recent discoveries co-led by scientists at Cedars-Sinai may help lead to new ways to treat patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and problems with movement.
An innovative mobile phone application was found to be as good as expert gastroenterologists at characterizing stool specimens, according to a study by Cedars-Sinai. The artificial intelligence (AI) used in the smartphone app also outperformed reports by patients describing their stool specimens.
Studies have shown that the way LGBTQ+ patients are screened, diagnosed and treated for cancer may put them at a significant disadvantage compared to cisgender heterosexual patients.
Cedars-Sinai physicians and scientists will share their latest advancements and research at Digestive Disease Week, known as DDW, an international scientific and clinical meeting featuring the work of physicians and researchers in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. DDW will take place May 21-24 in San Diego, California, and is available for virtual attendance.
Cardiovascular disease is the primary cause of pregnancy‐related death, yet a new national survey led by doctors at the Smidt Heart Institute at Cedars-Sinai suggests that few cardiologists, trainees or care team members are trained in cardio-obstetrics, a specialty that brings together experts from cardiology, obstetrics and primary care.
Pioneering breast cancer surgeon, clinician and researcher Armando E. Giuliano, MD-who helped introduce sentinel lymph node biopsy in the early 1990s, sparing many women the need for major breast cancer surgery-has been named regional medical director of the Cedars-Sinai Cancer Breast Oncology Program.
There's a huge urgency worldwide to find new therapies that help patients with amyotrophic lateral sclerosis (ALS), a fatal neurological disorder that causes people to eventually lose the ability to walk, talk, eat and breathe. In recognition of ALS Awareness Month, Dr. Deepti Lall shares why she’s optimistic about scientific advances for this fatal disease
Deaths involving alcohol use disorder increased dramatically during the pandemic, according to a new study by Cedars-Sinai investigators. The study also found that young adults 25 to 44 years old experienced the steepest upward trend in alcohol use disorder mortality.
Kimberly Gregory, MD, MPH, director of Maternal-Fetal Medicine and vice chair of Women's Healthcare Quality and Performance Improvement in the Department of Obstetrics and Gynecology at Cedars-Sinai, has been awarded the Luella Klein Lifetime Achievement Award by the American College of Obstetricians and Gynecologists (ACOG.)
Cedars-Sinai urology experts will present their latest advances in urologic medicine at the annual scientific meeting of the American Urological Association (AUA) in New Orleans May 13-16, 2022. Among over 2,200 abstracts, one by Alexandra Dubinskaya, MD, a female pelvic medicine and reconstructive surgery (FPMRS) specialist—Is It Time for FPMRS to Prescribe Vibrators?—was selected to be included in the 117th AUA press session on May 13, 2022, at 9 a.m. CT.
Stanley C. Jordan, MD, director of the Cedars-Sinai Nephrology and Transplant Immunology programs in the Cedars-Sinai Comprehensive Transplant Center, has been elected to the Association of American Physicians (AAP).
Treating pregnant women with opioid use disorder can help minimize opioid-related brain abnormalities in their newborns. Led by scientists at Cedars-Sinai, this is the first study to report evidence validating the benefits of using medication for opioid use disorder during pregnancy.
Karla Lopez was nearing the end of her first year of nursing school when she was diagnosed with colorectal cancer. It was a scary setback, but she wouldn't let it stop her. "I wanted to become an amazing nurse," she said, "so I fought through and … here I am a pediatric nurse.” Video Available.
A new Cedars-Sinai study shows that "Serenity Lounges"–break rooms equipped with massage chairs and other relaxation tools–reduced feelings of stress, anxiety and burnout among nurses.
Falls and broken bones are common among older adults, but they're not a natural part of aging. That's why Cedars-Sinai geriatricians created a bone health and falls risk consultation program to catch at-risk people before they break a bone or help them avoid another fracture in the future.
Cedars-Sinai geriatrics experts will present their latest advances in research and care in person at the annual scientific meeting of the American Geriatrics Society (AGS) in Orlando May 12-14, sharing innovations to improve both the quality of patient care and quality of life for older adults.
Nurse education is the key to successfully screening women for postpartum depression, which affects some 15% of mothers, according to a new quality improvement (QI) study from Cedars-Sinai.
More than 300 oral and poster presentations from the nation’s experts in gynecological and obstetrical health will be shared at the Annual Clinical and Scientific Meeting of the American College of Obstetricians & Gynecologists (ACOG ACSM). The conference takes place in San Diego from May 6-8.
In June of 2021, retired nurse Linda Leaming, 70, of LaVerne, was admitted to Cedars-Sinai after suffering a stroke. She was delirious and refusing to eat and drink, and her husband, Rich Leaming, struggled with decisions about her care. Neuropalliative specialist Jessica Besbris, MD, director of Neuropalliative Care and the Neurology Supportive Care Medicine Program at Cedars-Sinai, came to his aid.
This tipsheet highlights the latest medical discoveries and faculty news at Cedars-Sinai. Links to full news releases are included with each item.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
